Reticular thalamic hyperexcitability drives autism spectrum disorder behaviors in the Cntnap2 model of autism.

Scientists studied mice with autism-like behaviors and found that a brain region called the reticular thalamic nucleus was overactive. This overactivity was linked to seizures, repetitive behaviors, and hyperactivity. When researchers used medications and genetic techniques to calm this brain region, the autism-like behaviors improved significantly. This suggests this brain area could be an important target for future autism treatments.

This preclinical study investigated the role of the reticular thalamic nucleus (RT) in autism spectrum disorder using Cntnap2 knockout mice. Researchers found that these mice exhibited increased seizure susceptibility, hyperactivity, and repetitive behaviors alongside RT hyperexcitability characterized by enhanced oscillations and burst firing. Electrophysiological recordings revealed elevated T-type calcium currents in RT neurons, with in vivo monitoring confirming behavior-associated increases in RT activity. Importantly, both pharmacological intervention with Z944 (T-type calcium channel blocker) and chemogenetic suppression using DREADD technology significantly improved ASD-related behaviors.

These findings suggest RT hyperexcitability as a mechanistic driver of autism behaviors and identify the RT as a potential therapeutic target for addressing core ASD symptoms.

Identifies reticular thalamic hyperexcitability as potential therapeutic target for autism. T-type calcium channel blockers may offer treatment avenue for core autism behaviors and comorbidities. However, human studies needed to validate translation from mouse model findings.

Study conducted in mouse model only; sample sizes not reported; unclear how findings translate to human autism; limited to one genetic model (Cntnap2); intervention effects may be temporary or have side effects not assessed.

Autism spectrum disorders (ASDs) are neurodevelopmental conditions characterized by social deficits, repetitive behaviors, and comorbidities such as sensory abnormalities, sleep disturbances, and seizures. Although thalamocortical circuit dysfunction has been implicated in these symptoms, its precise roles in ASD pathophysiology remain poorly understood. Here, we examine the specific contribution of the reticular thalamic nucleus (RT), a key modulator of thalamocortical activity, to ASD-related behavioral deficits using aknockout mouse model.mice displayed increased seizure susceptibility, locomotor activity, and repetitive behaviors. Electrophysiological recordings revealed enhanced intrathalamic oscillations and burst firing in RT neurons, accompanied by elevated T-type calcium currents.

In vivo fiber photometry confirmed behavior-associated increases in RT population activity. Notably, pharmacological and chemogenetic suppression of RT excitability via Z944, a T-type calcium channel blocker, and via C21 activation of the inhibitory DREADD hM4Di significantly improved ASD-related behaviors. These findings identify RT hyperexcitability as a mechanistic driver of ASD and highlight RT as a potential therapeutic target.